ATE382338T1 - Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten - Google Patents

Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten

Info

Publication number
ATE382338T1
ATE382338T1 AT03006160T AT03006160T ATE382338T1 AT E382338 T1 ATE382338 T1 AT E382338T1 AT 03006160 T AT03006160 T AT 03006160T AT 03006160 T AT03006160 T AT 03006160T AT E382338 T1 ATE382338 T1 AT E382338T1
Authority
AT
Austria
Prior art keywords
hydrated
quinolone
pharmaceutical compositions
compositions containing
carbonic acid
Prior art date
Application number
AT03006160T
Other languages
English (en)
Inventor
Adnan Badwan
Lina Nabulsi
Mahmoud Omari
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Application granted granted Critical
Publication of ATE382338T1 publication Critical patent/ATE382338T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
AT03006160T 2003-03-19 2003-03-19 Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten ATE382338T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03006160A EP1459739B1 (de) 2003-03-19 2003-03-19 Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäure enthalten

Publications (1)

Publication Number Publication Date
ATE382338T1 true ATE382338T1 (de) 2008-01-15

Family

ID=32798836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03006160T ATE382338T1 (de) 2003-03-19 2003-03-19 Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten

Country Status (7)

Country Link
US (1) US20040224014A1 (de)
EP (1) EP1459739B1 (de)
JP (1) JP2004339198A (de)
AT (1) ATE382338T1 (de)
DE (1) DE60318384T2 (de)
DK (1) DK1459739T3 (de)
ES (1) ES2297067T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1868581T3 (pl) * 2005-04-11 2012-08-31 Abbvie Inc Kompozycje farmaceutyczne słabo rozpuszczalnych leków o polepszonych profilach rozpuszczania
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
SI2594272T1 (sl) * 2005-05-18 2018-10-30 Horizon Orphan Llc Aerosolizirani fluorokinoloni in njih uporaba
CN101541310B (zh) 2006-12-13 2012-11-07 弗·哈夫曼-拉罗切有限公司 缬更昔洛韦的粉末制剂
PL2344129T3 (pl) 2008-10-07 2018-07-31 Horizon Orphan Llc Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
AU2010289326B2 (en) 2009-09-04 2015-09-24 Horizon Therapeutics U.S. Holding Llc Use of aerosolized levofloxacin for treating cystic fibrosis
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 １－シクロプロピル－８－（ジフルオロメトキシ）－７－［（１ｒ）－１－メチル－２，３－ジヒドロ－１ｈ－イソインドール－５－イル］－４－オキソ－１，４－ジヒドロキノリン－３－カルボン酸のメタンスルホン酸塩水和物含有錠剤
CN105338982B (zh) 2013-04-25 2017-10-10 杏林制药株式会社 固体药用组合物
JP5700740B1 (ja) 2013-04-25 2015-04-15 杏林製薬株式会社 固形医薬組成物
WO2016063542A1 (ja) 2014-10-23 2016-04-28 杏林製薬株式会社 固形医薬組成物
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
CN107115312A (zh) * 2017-05-17 2017-09-01 湖南新汇制药股份有限公司 一种诺氟沙星片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IT1319664B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.

Also Published As

Publication number Publication date
DK1459739T3 (da) 2008-05-19
DE60318384D1 (de) 2008-02-14
JP2004339198A (ja) 2004-12-02
DE60318384T2 (de) 2009-02-19
ES2297067T3 (es) 2008-05-01
US20040224014A1 (en) 2004-11-11
EP1459739A1 (de) 2004-09-22
EP1459739B1 (de) 2008-01-02

Similar Documents

Publication Publication Date Title
ATE382338T1 (de) Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten
ATE550038T1 (de) Orale darreichungsform enthaltend einen pde-4 hemmer als wirkstoff und polyvinylpyrrolidone als hilfstoff
PT785775E (pt) Formulacoes opioides extrudidas por fusao administraveis oralmente
NO20003196L (no) Umiddelbart opplösende doseringsformulering
HUP0303810A3 (en) Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them
IL179718A0 (en) Pharmaceutical composition containing irbesartan
ATE376423T1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
ATE383859T1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
ATE392889T1 (de) Orale antimikrobielle pharmazeutische zusammensetzungen
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
ES2283638T3 (es) Preparacion bebible que comprende ketoprofeno y su empleo en el tratamiento simultaneo de enfermedades respiratorias en un grupo de animales.
ATE315395T1 (de) Pharmazeutische zusammensetzungen, die faropenem natrium und eine diamineacetat verbindung zur verbesserung der magen-darm trakt absorption enthalten
NO20041383L (no) Flashsmelte oral doseringsformulering
MA30554B1 (fr) Malates et formes polymorphes de l'acide ( 3s,5s)-7-[3-amino-5-methyl-piperidinyl ]-1-cyclopropyl-1,4-dihydro-8- methoxy-4-oxo-3-quinoleine-carboxylique
HRP20090022T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
ATE285779T1 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
TW200744583A (en) Statin stabilizing dosage formulations
DE60117523D1 (de) Orale zubereitung chlorhexidin und maltitol oder erythritol oder deren mischung enthaltend
RU2007105450A (ru) Лечение и профилактика заболеваний и инфекций свиней и домашней птицы
JO2567B1 (en) Non-water-absorbing pharmaceutical formula containing non-hydrated carboxylic quinoline acids
ATE355830T1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
ATE429227T1 (de) Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats
JPH04305504A (ja) 粘稠状殺菌剤組成物
SE0103613D0 (sv) Novel formulation
FR2874324B1 (fr) Composition veterinaire antibacterienne orale a base d'acide lactique et d'acide formique

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties